Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level and high-sensitivity C-reactive protein concentration in autoimmune hepatitis

Hepatology Research

Volumn 46, Issue 7, 2016, Pages 613-621

  Nishikawa, Hiroki ^a   Enomoto, Hirayuki ^a   Iwata, Yoshinori ^a   Hasegawa, Kunihiro ^a   Nakano, Chikage ^a   Takata, Ryo ^a   Nishimura, Takashi ^a   Yoh, Kazunori ^a   Aizawa, Nobuhiro ^a   Sakai, Yoshiyuki ^a   Ikeda, Naoto ^a   Takashima, Tomoyuki ^a   Iijima, Hiroko ^a   Nishiguchi, Shuhei ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

autoimmune hepatitis; high sensitivity C reactive protein; inflammation activity; liver fibrosis; Wisteria floribunda agglutinin positive Mac 2 binding protein

Indexed keywords

AGGLUTININ; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BINDING PROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; HYALURONIC ACID; UNCLASSIFIED DRUG; WISTERIA FLORIBUNDA AGGLUTININ POSITIVE MAC 2 BINDING PROTEIN;

ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

EID: 84975060979     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12596     Document Type: Article

References (36)

1. Manns MP, Lohse AW, Vergani D. Autoimmune hepatitis - Update 2015. J Hepatol 2015 62(1S): S100–1.
2. Ikeda A, Aoki N, Kido M, et al. Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice. Hepatology 2014 60(1): 224–36.
3. Grunwald D, Kothari D, Malik R. Noninvasive markers in the assessment and management of autoimmune liver diseases. Eur J Gastroenterol Hepatol 2014 26(10): 1065–72.
4. Dhaliwal HK, Hoeroldt BS, Dube AK, et al. Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis. Am J Gastroenterol 2015 May 26 [Epub ahead of print].
5. Muratori P, Lalanne C, Fabbri A, Cassani F, Lenzi M, Muratori L. Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype. Aliment Pharmacol Ther 2015 41(12): 1281–7.
6. Dyson JK, Webb G, Hirschfield GM, et al. Unmet clinical need in autoimmune liver diseases. J Hepatol 2015 62(1): 208–18.
7. Czaja AJ. Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets. Aliment Pharmacol Ther 2014 40(3): 261–79.
8. Feld JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology 2005 42: 53–62.
9. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006 354: 54–66.
10. Yang F, Wang Q, Jia J, Ma X. Autoimmune Hepatitis: East Meets West. J Gastroenterol Hepatol 2015 Mar 13 [Epub ahead of print].
11. Abe M, Mashiba T, Zeniya M, Yamamoto K, Onji M. Tsubouchi H; Autoimmune Hepatitis Study Group-Subgroup of the Intractable Hepato-Biliary Disease Study Group in Japan. Present status of autoimmune hepatitis in Japan: a nationwide survey. J Gastroenterol 2011 46(9): 1136–41.
12. Onji M, Zeniya M, Yamamoto K, Tsubouchi H. Autoimmune hepatitis: Diagnosis and treatment guide in Japan, 2013. Hepatol Res 2014 44(4): 368–70.
13. Czaja AJ. Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis. Aliment Pharmacol Ther 2014 39(4): 385–406.
14. Yamamoto K, Miyake Y, Ohira H, et al. Prognosis of autoimmune hepatitis showing acute presentation. Hepatol Res 2013 43(6): 630–8.
15. Czaja AJ. Current and prospective pharmacotherapy for autoimmune hepatitis. Expert Opin Pharmacother 2014 15(12): 1715–36.
16. Carbone M, Neuberger JM. Autoimmune liver disease, autoimmunity and liver transplantation. J Hepatol 2014 60(1): 210–23.
17. Fujiyoshi M, Kuno A, Gotoh M, et al. Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma. J Gastroenterol 2015 Mar 15 [Epub ahead of print].
18. Toshima T, Shirabe K, Ikegami T, et al. A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis. J Gastroenterol 2015 50(1): 76–84.
19. Yamasaki K, Tateyama M, Abiru S, et al. Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. Hepatology 2014 60(5): 1563–70.
20. Tamaki N, Kurosaki M, Kuno A, et al. Wisteria floribunda agglutinin positive human Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients. Hepatol Res 2015 Jan 6 [Epub ahead of print].
21. Hanai T, Shiraki M, Ohnishi S, et al. Impact of serum glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein levels on liver functional reserves and mortality in patients with liver cirrhosis. Hepatol Res 2015 Jan 6 [Epub ahead of print].
22. Kuno A, Ikehara Y, Tanaka Y, et al. A serum “sweet-doughnut” 272 protein facilitates fibrosis evaluation and therapy assessment in patients 273 with viral hepatitis. Sci Rep 2013 3: 1065.
23. Kuno A, Sato T, Shimazaki H, et al. Reconstruction of a robust glycodiagnostic agent supported by multiple lectin-assisted glycan profiling. Proteomics Clin Appl 2013 7(9–10): 642–7.
24. Umemura T, Joshita S, Sekiguchi T, et al. Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis. Am J Gastroenterol 2015 110(6): 857–64.
25. Sasaki R, Yamasaki K, Abiru S, et al. Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response. PLoS One 2015 10(6) : e0129053.
26. Abe M, Miyake T, Kuno A, et al. Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease. J Gastroenterol 2014 Oct 18 [Epub ahead of print].
27. Ma LN, Liu XY, Luo X, et al. Serum high-sensitivity C-reactive protein are associated with HBV replication, liver damage and fibrosis in patients with chronic hepatitis B. Hepatogastroenterology 2015 62(138): 368–72.
28. Fujiwara N, Tateishi R, Nakagawa H, et al. Slight elevation of high-sensitivity C-reactive protein to predict recurrence and survival in patients with early stage hepatitis C-related hepatocellular carcinoma. Hepatol Res 2015 45(6): 645–55.
29. Yoneda M, Mawatari H, Fujita K, et al. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol 2007 42(7): 573–82.
30. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999 31(5): 929–38.
31. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003 38(2): 518–26.
32. Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006 43(6): 1317–25.
33. Mahler M, Meroni PL, Bossuyt X, Fritzler MJ. Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J Immunol Res 2014 2014: 315179.
34. Iwata K, Enomoto H, Nishiguchi S, et al. Serum zinc value in patients with hepatitis virus-related chronic liver disease: association with the histological degree of liver fibrosis and with the severity of varices in compensated cirrhosis. J Clin Biochem Nutr 2014 55(2): 147–52.
35. Fernandez M, Trépo E, Degré D, et al. Transient elastography using Fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease. Eur J Gastroenterol Hepatol 2015 May 18 [Epub ahead of print].
36. Xiao G, Yang J, Yan L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology 2015 61(1): 292–302.